v3.26.3
Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2026
Jun. 30, 2025
Current assets    
Cash and cash equivalents $ 8,387 $ 3,100
Short-term investments 2,947 15,108
Accounts receivable 124 485
Inventory, net:    
Raw materials 2,926 2,194
Work-in-process 9 425
Finished goods 1,179 310
Prepaid expenses and other current assets 354 353
Total current assets 15,926 21,975
Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization 2,383 2,395
Intangible assets, net 50 48
Operating lease assets 1,834 2,225
Other assets, net 314 346
Total assets 20,507 26,989
Liabilities, Current [Abstract]    
Accounts payable 581 1,066
Payroll related accruals 482 529
Accrued expenses and other liabilities 912 451
Operating and Finance Leases, Liability, Current 282 405
Total current liabilities 2,257 2,451
Accrued expenses and other liabilities, net of current portion 54 164
Operating and Finance Leases, Liability, Noncurrent 2,024 2,274
Total liabilities 4,335 4,889
Commitments and contingencies (Note 14)
Stockholders’ equity    
Convertible preferred stock, $0.001 par value, 2,500,000 shares authorized; 280,898 shares of Series D issued and outstanding at June 30, 2026 and 2025, respectively 0 0
Common stock, $0.001 par value, 250,000,000 shares authorized at June 30, 2026 and 2025 respectively; 2,009,050 and 1,769,269 shares issued at June 30, 2026 and 2025 respectively; 1,998,734 and 1,758,953 outstanding at June 30, 2026 and 2025, respectively 190,643 190,643
Treasury shares, 10,316 shares at June 30, 2026 and 2025, respectively (119) (119)
Additional paid-in capital 91,261 83,310
Accumulated deficit (265,297) (250,870)
Accumulated other comprehensive loss (316) (864)
Total stockholders’ equity 16,172 22,100
Total liabilities and stockholders’ equity $ 20,507 $ 26,989